BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS
Utilizes next-generation sequencing (NGS) to identify mutations in the BCR-ABL kinase domain, which can impact the treatment of chronic myelogenous leukemia (CML). It informs treatment strategies.
Also known asBcr-abl Kinase Domain Mutation Analysis By Ngs Bcr-abl Kinase Domain Mutation Analysis By Ngs
Test details
Preparations
No special preparations needed
Test included
BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS includes 1 parameter
- Specimen
Test code
G635
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Edta Whole Blood | Lavender Vacutainer | 3 ML |
Specimen stability information
Edta Whole Blood
Specimen rejection criteria
Test run frequency
Every Day TIME - 10:00
Turn around time
17 Working Days
Performing locations
Department
- Advanced Molecular Diagnostics R&d
CPT and Loinc codes
BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS
Package price
₹11000
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestBCR-ABL1 Kinase Domain Mutation (IRMA) by NGS
₹11000